Product image of Moxifloxacina Demo (Moxifloxacin) supplied by GNH India

Moxifloxacina Demo

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacina Demo (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacina Demo, is a fluoroquinolone presented as an oral dosage form for systemic use. It treats a range of bacterial infections, particularly in adult patients with respiratory, sinus, bronchial, or skin involvement.

GNH India supplies Moxifloxacina Demo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Demo Abee

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacina Demo is indicated for several bacterial infections affecting the respiratory and integumentary systems.

  • Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical outcomes.
  • Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
  • Acute exacerbation of chronic bronchitis: shortens symptom duration and prevents complications.
  • Skin and soft tissue infections: eliminates susceptible organisms and promotes wound healing.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. By stabilizing the enzyme‑DNA complex, it prevents the resealing of DNA strands, leading to bacterial cell death. This bactericidal action is broad‑spectrum against Gram‑positive, Gram‑negative, and atypical respiratory pathogens.

Side Effects

Moxifloxacina Demo may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Rash: mild skin erythema or itching.

Serious or Rare Side Effects

  • Tendon rupture: sudden pain and loss of function, especially in the Achilles tendon.
  • QT interval prolongation: cardiac rhythm disturbances requiring monitoring.
  • Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome.
  • Peripheral neuropathy: persistent numbness or tingling.
  • Hepatotoxicity: elevated liver enzymes or jaundice.

Precautions & Warnings

Before prescribing Moxifloxacina Demo, clinicians should consider several safety measures.

  • Assess cardiac history: avoid in patients with known QT prolongation.
  • Review tendon health: discontinue if tendon pain or swelling occurs.
  • Monitor renal function: dose adjustment may be needed in severe impairment.
  • Caution in elderly: higher risk of CNS effects and tendon injury.
  • Avoid in known hypersensitivity to fluoroquinolones.
  • Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Avoid Interactions

Moxifloxacina Demo can alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

  • Antacids containing magnesium or aluminum: markedly reduce absorption; separate administration by at least 2 hours.
  • Warfarin: increased anticoagulant effect; monitor INR closely.
  • Theophylline: elevated serum levels may cause toxicity; consider dose reduction.

Moderate Interactions (Monitor Closely)

  • NSAIDs (e.g., ibuprofen, naproxen): increased risk of CNS stimulation and seizures.
  • Corticosteroids: heightened chance of tendon rupture; advise patients to report tendon pain promptly.
  • Cyclosporine: may raise cyclosporine concentrations; monitor renal function and drug levels.

Frequently Asked Questions

Moxifloxacina Demo is prescribed for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and skin or soft‑tissue infections caused by susceptible bacteria. It targets the pathogens most commonly responsible for these conditions.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. By preventing the resealing of DNA strands, it halts bacterial cell division and leads to rapid bacterial death, providing a bactericidal effect across a broad spectrum of organisms.

The specific dose and duration of Moxifloxacina Demo are determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Patients should follow the exact regimen written on their prescription.

Safety data for moxifloxacin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Moxifloxacin offers a broader spectrum against atypical respiratory pathogens and a longer half‑life, allowing once‑daily dosing in many cases. Compared with older fluoroquinolones such as ciprofloxacin, it has enhanced activity against Gram‑positive organisms and a lower propensity for drug‑interaction with certain antacids.

Moxifloxacina Demo should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and sources of heat to maintain its stability and potency.

Moxifloxacina Demo is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concomitant intake of antacids containing magnesium or aluminum within two hours of the dose to ensure proper absorption.

Serious risks include tendon rupture (especially in the Achilles tendon), QT interval prolongation leading to cardiac arrhythmias, severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome, peripheral neuropathy, and hepatotoxicity. Patients should seek immediate medical attention if they experience any of these symptoms.

Moxifloxacina Demo is contraindicated in individuals with a known hypersensitivity to moxifloxacin, other fluoroquinolones, or any of the product’s excipients. It should also be avoided in patients with a history of tendon disorders related to fluoroquinolone use, uncontrolled QT prolongation, or those taking medications that significantly increase the risk of serious cardiac events.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT